Shire Plc has finally won over Baxalta as it has added cash to a takeover bid bring the deal to $32 billion. The combined company will become the largest maker in the world of drugs to treat rare diseases. The deal’s price includes 0.148 of the American depository receipts of Shire and cash of $18 […]